BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30142110)

  • 1. Outcomes of Impella 5.0 in Cardiogenic Shock: A Systematic Review and Meta-analysis.
    Batsides G; Massaro J; Cheung A; Soltesz E; Ramzy D; Anderson MB
    Innovations (Phila); 2018; 13(4):254-260. PubMed ID: 30142110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    Saito S; Okubo S; Matsuoka T; Hirota S; Yokoyama S; Kanazawa Y; Takei Y; Tezuka M; Tsuchiya G; Konishi T; Shibasaki I; Ogata K; Fukuda H
    J Cardiol; 2024 Apr; 83(4):228-235. PubMed ID: 37926367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
    Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impella support as a bridge to heart surgery in patients with cardiogenic shock.
    Saito S; Shibasaki I; Matsuoka T; Niitsuma K; Hirota S; Kanno Y; Kanazawa Y; Tezuka M; Takei Y; Tsuchiya G; Konishi T; Ogata K; Fukuda H
    Interact Cardiovasc Thorac Surg; 2022 Jul; 35(2):. PubMed ID: 35373286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
    Doshi R; Patel K; Decter D; Jauhar R; Meraj P
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device.
    Nersesian G; Tschöpe C; Spillmann F; Gromann T; Roehrich L; Mueller M; Mulzer J; Starck C; Falk V; Schoenrath F; Potapov E
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):475-482. PubMed ID: 32879947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery.
    Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I
    J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support.
    Griffith BP; Anderson MB; Samuels LE; Pae WE; Naka Y; Frazier OH
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):548-54. PubMed ID: 22405676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group.
    Fried J; Farr M; Kanwar M; Uriel N; Hernandez-Montfort J; Blumer V; Li S; Sinha SS; Garan AR; Li B; Hall S; Hickey GW; Mahr C; Nathan S; Schwartzman A; Kim J; Ton VK; Vishnevsky OA; Vorovich E; Abraham J; Zweck E; Guglin M; Vallabhajosyula S; Kataria R; Walec KD; Zazzali P; Kong Q; Sangal P; Burkhoff D; Kapur NK
    J Heart Lung Transplant; 2024 Jun; ():. PubMed ID: 38834162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved clinical outcomes associated with the Impella 5.5 compared to the Impella 5.0 in contemporary cardiogenic shock and heart failure patients.
    Ramzy D; Soltesz EG; Silvestry S; Daneshmand M; Kanwar M; D'Alessandro DA
    J Heart Lung Transplant; 2023 May; 42(5):553-557. PubMed ID: 36841643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of hundred large Impella implantations in cardiogenic shock patients based on individual clinical scenarios.
    Sugimura Y; Bauer S; Immohr MB; Mehdiani A; Rellecke P; Tudorache I; Horn P; Westenfeld R; Boeken U; Aubin H; Lichtenberg A; Akhyari P
    Artif Organs; 2023 Dec; 47(12):1874-1884. PubMed ID: 37724611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock.
    Kuchibhotla S; Esposito ML; Breton C; Pedicini R; Mullin A; O'Kelly R; Anderson M; Morris DL; Batsides G; Ramzy D; Grise M; Pham DT; Kapur NK
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival.
    Meraj PM; Doshi R; Schreiber T; Maini B; O'Neill WW
    J Interv Cardiol; 2017 Jun; 30(3):256-263. PubMed ID: 28419573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.